These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 34869006)
1. A Hypoxia-Related Long Non-Coding RNAs Signature Associated With Prognosis in Lower-Grade Glioma. Feng Q; Qian C; Fan S Front Oncol; 2021; 11():771512. PubMed ID: 34869006 [TBL] [Abstract][Full Text] [Related]
2. Hypoxia-Related lncRNA Correlates With Prognosis and Immune Microenvironment in Lower-Grade Glioma. Xu S; Tang L; Liu Z; Luo C; Cheng Q Front Immunol; 2021; 12():731048. PubMed ID: 34659218 [TBL] [Abstract][Full Text] [Related]
3. Identification of Iron Metabolism-Related Genes as Prognostic Indicators for Lower-Grade Glioma. Xu S; Wang Z; Ye J; Mei S; Zhang J Front Oncol; 2021; 11():729103. PubMed ID: 34568059 [TBL] [Abstract][Full Text] [Related]
4. Identification and validation of an individualized prognostic signature of lower-grade glioma based on nine immune related long non-coding RNA. Maimaiti A; Jiang L; Wang X; Shi X; Pei Y; Hao Y; Paerhati H; Zibibula Y; Abudujielili A; Kasimu M Clin Neurol Neurosurg; 2021 Feb; 201():106464. PubMed ID: 33454543 [TBL] [Abstract][Full Text] [Related]
5. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma. Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618 [TBL] [Abstract][Full Text] [Related]
6. Establishment and Validation of a Ferroptosis-Related lncRNA Signature for Prognosis Prediction in Lower-Grade Glioma. Huang QR; Li JW; Yan P; Jiang Q; Guo FZ; Zhao YN; Mo LG Front Neurol; 2022; 13():861438. PubMed ID: 35832170 [TBL] [Abstract][Full Text] [Related]
7. Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma. Zhang M; Wang X; Chen X; Zhang Q; Hong J Front Genet; 2020; 11():363. PubMed ID: 32351547 [TBL] [Abstract][Full Text] [Related]
8. 5-Methylcytosine Related LncRNAs Reveal Immune Characteristics, Predict Prognosis and Oncology Treatment Outcome in Lower-Grade Gliomas. Zhang J; Wang N; Wu J; Gao X; Zhao H; Liu Z; Yan X; Dong J; Wang F; Ba Y; Ma S; Jin J; Du J; Ji H; Hu S Front Immunol; 2022; 13():844778. PubMed ID: 35309316 [TBL] [Abstract][Full Text] [Related]
9. An Effective Hypoxia-Related Long Non-Coding RNAs Assessment Model for Prognosis of Clear Cell Renal Carcinoma. Zhang H; Qin C; Liu HW; Guo X; Gan H Front Oncol; 2021; 11():616722. PubMed ID: 33692953 [TBL] [Abstract][Full Text] [Related]
10. Machine learning-based screening of an epithelial-mesenchymal transition-related long non-coding RNA signature reveals lower-grade glioma prognosis and the tumor microenvironment and predicts antitumor therapy response. Wang N; Gao X; Ji H; Ma S; Wu J; Dong J; Wang F; Zhao H; Liu Z; Yan X; Li B; Du J; Zhang J; Hu S Front Mol Biosci; 2022; 9():942966. PubMed ID: 36090045 [TBL] [Abstract][Full Text] [Related]
11. Identification and Verification on Prognostic Index of Lower-Grade Glioma Immune-Related LncRNAs. Wen J; Wang Y; Luo L; Peng L; Chen C; Guo J; Ge Y; Li W; Jin X Front Oncol; 2020; 10():578809. PubMed ID: 33330055 [TBL] [Abstract][Full Text] [Related]
12. A Novel Four-Gene Signature Associated With Immune Checkpoint for Predicting Prognosis in Lower-Grade Glioma. Xiao Y; Cui G; Ren X; Hao J; Zhang Y; Yang X; Wang Z; Zhu X; Wang H; Hao C; Duan H Front Oncol; 2020; 10():605737. PubMed ID: 33381460 [TBL] [Abstract][Full Text] [Related]
13. Machine Learning-Based Integration Develops a Pyroptosis-Related lncRNA Model to Enhance the Predicted Value of Low-Grade Glioma Patients. Wu J; Lu L; Wang C; Jiang F J Oncol; 2022; 2022():8164756. PubMed ID: 35646114 [TBL] [Abstract][Full Text] [Related]
14. A nuclear transport-related gene signature combined with IDH mutation and 1p/19q codeletion better predicts the prognosis of glioma patients. Zhu Z; Lan Y; Wang L; Ge J; Wang J; Liu F; He Z; Zhang H; Luo M; Lin D; Tan Y; Xu Y; Luo T BMC Cancer; 2020 Nov; 20(1):1072. PubMed ID: 33167941 [TBL] [Abstract][Full Text] [Related]
15. A cuproptosis-related lncRNAs signature for prognosis, chemotherapy, and immune checkpoint blockade therapy of low-grade glioma. Yan X; Wang N; Dong J; Wang F; Zhang J; Hu X; Zhao H; Gao X; Liu Z; Li Y; Hu S Front Mol Biosci; 2022; 9():966843. PubMed ID: 36060266 [TBL] [Abstract][Full Text] [Related]
16. Multi-Omics Analysis Based on Genomic Instability for Prognostic Prediction in Lower-Grade Glioma. Cao Y; Zhu H; Liu W; Wang L; Yin W; Tan J; Zhou Q; Xin Z; Huang H; Xie D; Zhao M; Jiang X; Peng J; Ren C Front Genet; 2021; 12():758596. PubMed ID: 35069679 [No Abstract] [Full Text] [Related]
17. A novel cuproptosis-related LncRNA signature: Prognostic and therapeutic value for low grade glioma. Wen J; Zhao W; Shu X Front Oncol; 2022; 12():1087762. PubMed ID: 36776374 [TBL] [Abstract][Full Text] [Related]
18. Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma. Zhao J; Wang L; Wei B Biomed Res Int; 2020; 2020():3708231. PubMed ID: 32802843 [TBL] [Abstract][Full Text] [Related]
19. N6-Methylandenosine-Related lncRNAs Are Potential Biomarkers for Predicting the Overall Survival of Lower-Grade Glioma Patients. Tu Z; Wu L; Wang P; Hu Q; Tao C; Li K; Huang K; Zhu X Front Cell Dev Biol; 2020; 8():642. PubMed ID: 32793593 [TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of a Stemness Index-Associated Signature in Primary Lower-Grade Glioma. Zhang M; Wang X; Chen X; Guo F; Hong J Front Genet; 2020; 11():441. PubMed ID: 32431729 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]